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co-infected patients and the impact of co-infection on the efﬁcacy
of Peg-IFN/RBV combination therapy.
Methods & Materials: The clinical characteristics of HBV/HCV
co-infected patients and the virological responses to Peg-IFN/RBV
combination therapy in 89 HBV and HCV co-infected patients were
retrospectively analyzed. The primary outcome measurement of
antiviral treatment was SVR (seronegative of HCVRNA throughout
the 6-month post-treatment follow-up period).
Results: Of the 89 HBV/HCV co-infected patients, HCV strains
were dominant in 76 patients (85.4%), while HCV and HBV strains
were both dominant 13 patients (14.6%). HBV DNA load level and
HBeAg positive rate in HBV/HCV co-infected patients was signiﬁ-
cantly lower than that inHBVmono-infected group (p<0.01, 0.001,
respectively). Serum levels of ALT and AST in co-infected patients
were obviously higher than that inmono-infected group (p<0.001,
0.001, respectively). The SVR rate was signiﬁcantly lower in the
HBV/HCVco-infectedpatients compared to theHCVmono-infected
patients (p <0.05). However, the signiﬁcantly lower rate of SVR in
the co-infected group was observed among genotype-1 patients
(p <0.05) but not among genotype-2/3 patients (p >0.05). Partial
early virological response (pEVR) rates and virological response
at the end of treatment (ETVR) rates were signiﬁcantly higher in
patients co-infected with genotype 1 of HCV and HBV than those in
HCVmono-infectedpatients (p <0.01, 0.01, respectively). Nodiffer-
ences in rapidvirological response (RVR), completeearlyvirological
response (cEVR), and relapse were observed between co-infected
patients with non-genotype 1 of HCV and HBV and mono-infected
patients with non-genotype 1 of HCV.
Conclusion: Co-infection with HBV and non-genotype 1 of HCV
hasno impact onvirological responses toPeg-IFN/RBVcombination
therapy.
http://dx.doi.org/10.1016/j.ijid.2014.03.1083
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Background: Winter inﬂuenza planning is a part of health ser-
vices’ preparation for the annual increase in hospital admissions
due to respiratory virus infections in New Zealand. The diagnos-
tic virology service for Canterbury District Health Board’s hospitals
extended respiratory pathogen testing in 2012 using a multiplex
PCR test.
This study is an audit over 2 years of the outcomes of patients
requiring ICU admission for respiratory support, with either
inﬂuenza or another respiratory virus diagnosis.
Methods & Materials: Respiratory samples were tested using
the Fast-track Diagnostics (FTD) respiratory pathogen multiplex
PCR for the detection of 19 viruses.
The Laboratory Information System was searched for records of
all admitted patientswith a PCR respiratory virus diagnosis in 2012
and2013. Adult patients, 18 years andover requiring IntensiveCare
Unit respiratory support, were included.
The hospital electronic database was searched for patient
admission diagnosis, chronic illness, length of admission, antibiotic
prescribing and mortality related to the ICU admission.
Results:A total of 782 patients admitted to hospital had a respi-
ratory virus diagnosis. Of 312 adult patients with inﬂuenza, 15
required ICU support, ofwhomtwodied (13.3%),while, of 470 adult
patients with another respiratory virus, 35 required ICU support of
whom 10 died (28.6%).
Themost common admitting diagnosiswas “acute exacerbation
COPD” and “Pneumonia”, comprising 4 and 5 respectively for the
Inﬂuenza group, and 12 and 13 in the other virus group.
The most common premorbid condition was COPD, including 5
(33%) of the inﬂuenza group and 15 (43%) of the other virus group.
Length of stay for patients in the Inﬂuenza group was median 5
days (1-30 days) and other virus group median 5 days (1-24 days).
All but nine ICU patients received one or more antibiotics dur-
ing admission and eight of 15 patients with inﬂuenza received
Oseltamivir.
Conclusion: Adult patients with viral respiratory infections
other than inﬂuenza and requiring ICU admission have similar
length of stay, but increased mortality, as those with inﬂuenza in
ICU,. COPD is an important premorbid condition for severe out-
comes for all respiratoryvirus infections.Winter inﬂuenzaplanning
should include the planning for admission of patients with non-
inﬂuenza respiratory viruses.
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